Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.46403 | 71 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.83797 | 74 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.55821 | 72 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.80332 | 73 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.44973 | 71 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.58489 | 73 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.55334 | 72 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.76196 | 74 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.53023 | 71 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.45433 | 71 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.53939 | 72 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.79142 | 73 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.95072 | 65 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.5251 | 72 |